The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

Abstract With the heterogeneous use and interpretation of next-generation molecular imaging and approval of new treatment strategies, therapeutic decision-making for de novo metastatic hormone-sensitive prostate cancer (mHSPC) is becoming increasingly challenging. It is conceivable that patients are...

Full description

Saved in:
Bibliographic Details
Main Authors: Tessa van Elst, Niven Mehra, Sjaak Bloem, André N. Vis, Bart P. Wijsman, Daphne Luijendijk-de Bruin, Joyce M. van Dodewaard-de Jong, Pieter L. van den Berg, Jules Lavalaye, Shafak Aluwini, Derya Yakar, Daniela E. Oprea-Lager, Peter F. A. Mulders, Haiko J. Bloemendal, Jean-Paul A. van Basten
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Metastatic hormone-sensitive prostate cancer
Imaging
Treatments
Guidelines
Practice variation
Online Access:https://doi.org/10.1038/s41598-025-96065-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-96065-9

Similar Items